Neglecting the neglected: the objective evidence of underfunding in rheumatic heart disease.
| Autor: | Macleod CK; Department of Clinical Research, London School of Hygiene & Tropical Medicine, Keppel Street, London, UK., Bright P; Department of Immunology, Royal Free Hospital, 10 Pond St, Hampstead, London, UK., Steer AC; Division of Infection and Immunity, Murdoch Children's Research Institute, Royal Children's Hospital, Flemington Rd, Parkville, Australia., Kim J; International Vaccine Institute, SNU Research Park, 1 Gwanak-ro, Gwanak-gu, Seoul, South Korea., Mabey D; Department of Clinical Research, London School of Hygiene & Tropical Medicine, Keppel Street, London, UK., Parks T; Department of Clinical Research, London School of Hygiene & Tropical Medicine, Keppel Street, London, UK. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Transactions of the Royal Society of Tropical Medicine and Hygiene [Trans R Soc Trop Med Hyg] 2019 May 01; Vol. 113 (5), pp. 287-290. |
| DOI: | 10.1093/trstmh/trz014 |
| Abstrakt: | Background: Despite the substantial global burden of disease, rheumatic heart disease research receives little funding globally. Methods: Using data from the Global Burden of Disease Study and funding from the G-FINDER database, we propose a novel logarithmic disability neglect index (DNI) to describe disease burden using disability-adjusted life years relative to funding for 16 major tropical diseases. Results: Across a range of diseases, rheumatic heart disease received the least funding relative to disease burden (DNI=3.83). Other diseases facing similar underfunding include cysticercosis (DNI=2.71) and soil-transmitted helminths (DNI=2.41). Conclusions: Rheumatic heart disease remains severely underfunded relative to disease burden. (© The Author(s) 2019. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|